KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Apr 11, 2016 $5.16 $5.16 $5.16 $5.16 480 143
Apr 08, 2016 $5.19 $5.19 $5.19 $5.19 829 462
Apr 07, 2016 $5.34 $5.34 $5.34 $5.34 475 919
Apr 06, 2016 $5.25 $5.25 $5.25 $5.25 481 319
Apr 05, 2016 $5.10 $5.10 $5.10 $5.10 379 592
Apr 04, 2016 $5.03 $5.03 $5.03 $5.03 975 677
Apr 01, 2016 $4.90 $4.90 $4.90 $4.90 518 909
Mar 31, 2016 $4.82 $4.82 $4.82 $4.82 390 547
Mar 30, 2016 $4.83 $4.83 $4.83 $4.83 551 932
Mar 29, 2016 $4.91 $4.91 $4.91 $4.91 685 400
Mar 28, 2016 $4.47 $4.47 $4.47 $4.47 320 600
Mar 24, 2016 $4.57 $4.57 $4.57 $4.57 352 900
Mar 23, 2016 $4.40 $4.40 $4.40 $4.40 530 500
Mar 22, 2016 $4.82 $4.82 $4.82 $4.82 454 500
Mar 21, 2016 $4.50 $4.50 $4.50 $4.50 436 700
Mar 18, 2016 $4.53 $4.53 $4.53 $4.53 854 000
Mar 17, 2016 $4.21 $4.21 $4.21 $4.21 448 200
Mar 16, 2016 $4.21 $4.21 $4.21 $4.21 341 700
Mar 15, 2016 $4.22 $4.22 $4.22 $4.22 690 200
Mar 14, 2016 $4.51 $4.51 $4.51 $4.51 387 600
Mar 11, 2016 $4.49 $4.49 $4.49 $4.49 366 200
Mar 10, 2016 $4.35 $4.35 $4.35 $4.35 484 400
Mar 09, 2016 $4.48 $4.48 $4.48 $4.48 569 400
Mar 08, 2016 $4.59 $4.59 $4.59 $4.59 907 000
Mar 07, 2016 $4.76 $4.76 $4.76 $4.76 865 300
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT